Literature DB >> 7751811

A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease.

D Ameis1, G Brockmann, R Knoblich, M Merkel, R E Ostlund, J W Yang, P M Coates, J A Cortner, S V Feinman, H Greten.   

Abstract

Cholesteryl ester storage disease (CESD) results from inherited deficiencies of the lysosomal hydrolase, acid lipase (LAL; E.C. 3.1.1.13). To establish the molecular defects in LAL deficiency, two unrelated probands with severely reduced LAL activity were examined. DNA amplification by reverse-transcription polymerase chain reaction and subsequent sequence analysis of LAL cDNA identified two mutant alleles. Patient 1, presenting with hepatosplenomegaly, mildly elevated liver function tests, and hyperlipidemia, was homozygous for a deletion of nucleotides 823 to 894 of the LAL cDNA. This 72-bp deletion maintained the reading frame and resulted in a loss of 24 amino acids from the LAL protein. Analysis of genomic DNA revealed that the 72 bp corresponded to an exon of the LAL gene. A single G to A point mutation at the last exon position was observed in the genomic DNA of patient 1, indicating a splicing defect with consecutive exon skipping underlying the 72-bp deletion. Patient 2 was a compound heterozygote for the 72-bp deletion and a dinucleotide deletion at positions 967 and 968. This deletion resulted in a shifted reading frame carboxyterminal of codon 296, and 43 random amino acids followed the frame shift. A premature stop at codon 339 truncated the mutant LAL protein by 34 amino acids. Allele-specific hybridization confirmed that patient 1 was homozygous for the 72-bp deletion mutation, and that patient 2 was a compound heterozygote for the 72-bp deletion and the 2-bp deletion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751811

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

Review 1.  Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.

Authors:  Hemant Chatrath; Steven Keilin; Bashar M Attar
Journal:  Dig Dis Sci       Date:  2008-05-14       Impact factor: 3.199

2.  Intragenic deletion as a novel type of mutation in Wolman disease.

Authors:  Teresa M Lee; Mariko Welsh; Sonia Benhamed; Wendy K Chung
Journal:  Mol Genet Metab       Date:  2011-09-14       Impact factor: 4.797

3.  Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.

Authors:  Stuart A Scott; Benny Liu; Irina Nazarenko; Suparna Martis; Julia Kozlitina; Yao Yang; Charina Ramirez; Yumi Kasai; Tommy Hyatt; Inga Peter; Robert J Desnick
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

Review 4.  Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.

Authors:  Francis Aguisanda; Natasha Thorne; Wei Zheng
Journal:  Curr Chem Genom Transl Med       Date:  2017-01-30

5.  Early Discovery of Children With Lysosomal Acid Lipase Deficiency With the Universal Familial Hypercholesterolemia Screening Program.

Authors:  Ursa Sustar; Urh Groselj; Katarina Trebusak Podkrajsek; Matej Mlinaric; Jernej Kovac; Martin Thaler; Ana Drole Torkar; Ajda Skarlovnik; Tadej Battelino; Tinka Hovnik
Journal:  Front Genet       Date:  2022-07-12       Impact factor: 4.772

Review 6.  Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.

Authors:  Andrea Dardis; Emanuele Buratti
Journal:  Genes (Basel)       Date:  2018-02-06       Impact factor: 4.096

Review 7.  Genes Potentially Associated with Familial Hypercholesterolemia.

Authors:  Svetlana Mikhailova; Dinara Ivanoshchuk; Olga Timoshchenko; Elena Shakhtshneider
Journal:  Biomolecules       Date:  2019-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.